Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00440_DB00622_nanopub.RAeRZ94rnjrvrIWGM68I3bw43OYHMhvsH6HdGFGyOBNYg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00440_DB00622 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00440_DB00622 label "DDI between Trimethoprim and Nicardipine - The strong CYP2C9 inhibitor, Nicardipine, may decrease the metabolism and clearance of Trimethoprim, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimethoprim if Nicardipine is initiated, discontinued or dose changed. [drugbank_resource:DB00440_DB00622]" assertion.
- drugbank_resource:DB00440_DB00622 identifier "drugbank_resource:DB00440_DB00622" assertion.
- drugbank_resource:DB00440_DB00622 title "DDI between Trimethoprim and Nicardipine - The strong CYP2C9 inhibitor, Nicardipine, may decrease the metabolism and clearance of Trimethoprim, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimethoprim if Nicardipine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00622 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00440_DB00622 assertion.
- drugbank:DB00440 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00440_DB00622 assertion.